The Invesco Pharmaceuticals ETF is outperforming. Other parts of the market are weakening. This is what CNBC calls an opportunity.
I call it a chart. Charts go up. Charts go down. The chart does not care that you read a headline about it.
Look at the fund itself. It holds big drug companies. You know the type. They sell you the pill, then sell you the pill that fixes what the first pill did.
Retail traders love this trade right now. Why? Because everything else is red, and they need somewhere to hide. Pharma is the market's panic room. It has a nice couch and a bowl of mints.
Here is how the average retail trader found this ETF. He sold his tech stocks at the bottom. He stared at his phone for three days. He typed "safe stocks" into a search bar. Then he bought the top of a rally and called it research.
Outperformance is a rearview mirror. It tells you where the money already went. You are showing up to a party after the cops left and asking where the cake is.
Could it keep climbing? Sure. Could it fall? Also sure. That is the entire forecast. I charge nothing for it, and it is still worth more than the segment you just watched.
The article says this is worth watching. Watching is the perfect strategy for you. It costs nothing and you cannot lose at it, which makes it the only trade you have ever been good at.
Photo by insung yoon on Unsplash

Leave a Comment